Defence Therapeutics Sharpens Strategic Focus on Precision Drug Delivery to Unlock the Full Potential of Cancer Biologics Life Science Investing
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders Life Science Investing
Royalty Pharma to Announce Fourth Quarter and Full Year 2025 Financial Results on February 11, 2026 Life Science Investing
Corvus Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants Life Science Investing
LevelJump Enters into Cooperation Agreement with Concerned Shareholder; Announces Board Reconstitution Technology Investing
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab Life Science Investing
Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab Life Science Investing
PRF Technologies Files Its First Patent Application for Solar Plant Micro-Climate Forecast Modeling Designed to Improve Energy Production Forecast Accuracy Life Science Investing
Aytu BioPharma Highlights Opportunity for EXXUATM as New Way to Treat Major Depressive Disorder That Avoids Common Side Effects of Sexual Dysfunction and Significant Weight Gain following launch of EXXUA Life Science Investing
